comparemela.com

Latest Breaking News On - Salarius pharmaceuticals - Page 7 : comparemela.com

Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular dated August 16, 2023 - Form 6-K -Today at 06:08 am

Salarius Pharmaceuticals (NASDAQ:SLRX) Downgraded to Neutral at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH lowered shares of Salarius Pharmaceuticals (NASDAQ:SLRX – Free Report) from a buy rating to a neutral rating in a report issued on Friday, FlyOnTheWall reports. Salarius Pharmaceuticals Stock Performance NASDAQ:SLRX opened at $0.65 on Friday. Salarius Pharmaceuticals has a 52 week low of $0.61 and a 52 week high of $7.20. The […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.